Molecular Identity
Xanomeline Tartrate
(2R,3R)-2,3-dihydroxybutanedioic acid;3-hexoxy-4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazole
PubChem CID: 71456
2D Structure
Properties
C18H29N3O7S
Molecular Formula
431.50
Molecular Weight
g/mol
431.1726
Exact Mass
Da
182
TPSA
May have limited oral absorption
4
H-Bond Donors
11
H-Bond Acceptors
432
Complexity
SMILES
Canonical SMILES
SMILES: CCCCCCOC1=NSN=C1C2=CCCN(C2)C.C(C(C(=O)O)O)(C(=O)O)OIsomeric SMILES
SMILES: CCCCCCOC1=NSN=C1C2=CCCN(C2)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)OSynonyms(20)
Xanomeline tartrate152854-19-8LY246708 tartrateB80W7AUT8RDTXSID00165143LY-246708 TARTRATECOBENFY COMPONENT XANOMELINE TARTRATERefChem:195102DTXCID2087634Xanomeline tartrate [USAN]UNII-B80W7AUT8R3-(Hexyloxy)-4-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazole (2R,3R)-2,3-dihydroxysuccinatePyridine, 3-(4-(hexyloxy)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methyl-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1)Xanomeline tartrate (USAN)XANOMELINE TARTRATE [WHO-DD]
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Xanomeline Tartrate
Loading drug network...